top of page

The April 2024 winners: 3 new projects will be supported by the PSCC


We are delighted to announce that 3 new projects have been selected by the Pôle Cancer Paris Saclay (PSCC) to benefit from its support: H EPTA Medical, KWAN-TEK, and RivelaDx.


Congratulations to all team members for their remarkable innovations!

The Paris Saclay Cancer Cluster (PSCC) continues to accelerate the development of innovations in oncology, affirming its position as the first and only French biocluster dedicated to cancer.


With 36 cutting-edge oncology projects selected and supported, the #PSCC hashtag offers the most promising developers access to a comprehensive set of resources: expertise, networking, financing, data, samples, technologies, infrastructure, training, laboratories .


Join the ranks of selected projects

The PSCC maintains an open call for applications, providing a unique opportunity for oncology innovators to quickly advance their projects.


Comments


bottom of page